Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy is a research paper published in Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR001427
NINDS NIH HHS
Grant: R01 NS108781
National Institutes of Health
Grant: 5R01NS108781-05
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
National Institutes of Health
FWCI
2.44
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop
Additional file 1 of Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop